Vincere Biosciences Awarded $2.7 Million NIH Grant to Advance USP30 Inhibitor for Acute Kidney Injury

SBIR Phase II award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will support IND-enabling development of Vincere's USP30 inhibitor small molecule for acute kidney injury (AKI) Vincere's approach targets mitochondrial dysfunction and impaired...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.